Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024 as against Rs 25.86 crore during the previous quarter ended September 2023. Sales rose 12.13% to Rs 172.21 crore in the quarter ended September 2024 as against Rs 153.58 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 172.21 | 153.58 | 12 |
| OPM % | 26.67 | 24.28 | - |
| PBDT | 47.70 | 39.02 | 22 |
| PBT | 42.39 | 34.79 | 22 |
| NP | 4.20 | 25.86 | -84 |